(Q33278984)

English

What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs (English)

1 reference

Europe PubMed Central

25 July 2017

author name string

Sarah J Roffey

1

1 reference

Europe PubMed Central

25 July 2017

R Scott Obach

2

1 reference

Europe PubMed Central

25 July 2017

Jenny I Gedge

3

1 reference

Europe PubMed Central

25 July 2017

Dennis A Smith

4

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 January 2007

1 reference

Europe PubMed Central

25 July 2017

Drug Metabolism Reviews

1 reference

Europe PubMed Central

25 July 2017

39

1 reference

Europe PubMed Central

25 July 2017

1

1 reference

Europe PubMed Central

25 July 2017

17-43

1 reference

Europe PubMed Central

25 July 2017

Metabolic fate of zetidoline, a new neuroleptic agent, in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition and biotransformation of the acetylenic retinoid tazarotene in humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Mass balance studies, with a focus on anticancer drugs.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Trabectedin (Yondelis, formerly ET-743), a mass balance study in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetic and mass balance study of unlabelled and (14)C-labelled emedastine difumarate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism and excretion of capravirine, a new non-nucleoside reverse transcriptase inhibitor, alone and in combination with ritonavir in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Evaluation of the absorption, excretion and metabolism of [14C] etoperidone in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism and excretion of the antiepileptic/antimigraine drug, Topiramate in animals and humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism of Cefotaxime in Animals and Humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Identification of urinary metabolites of penticainide in the rat, dog, baboon and man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of [14C]FCE 22891, a penem antibiotic, following oral administration to healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of 14C-delmopinol in the healthy male volunteer.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a far

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism and disposition of imatinib mesylate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The disposition and metabolism of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in human subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The disposition and metabolic fate of 14C-meropenem in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Absorption of colesevelam hydrochloride in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism, pharmacokinetics, and excretion of a highly selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in human cytochrome P450 2D6 extensive and poor metabolizers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of posaconazole following single-dose oral administration in healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Studies on the mechanism of drug-binding to melanin

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Clinical pharmacokinetics of amiodarone

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Binding of drugs to eye melanin is not predictive of ocular toxicity

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics and metabolism of rosaramicin in humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The metabolic fate of the anti-androgenic agent, oxendolone, in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of radiolabeled imipenem and cilastatin in normal human volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolic disposition of 14C-bromfenac in healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of [14C]-labelled Losigamone and enantiomers after oral administration to healthy subjects.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The metabolic profile of azimilide in man: in vivo and in vitro evaluations

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Zatebradine: pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of falipamil after intravenous administration to humans.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The metabolism of nicardipine hydrochloride in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Mass balance study of [14C]M100240, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy male subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of fosinopril sodium in healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Clinical pharmacokinetics of mirtazapine

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Invited review: fluphenazine augments retinal oxidative stress

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of compound 58-112, a potential skeletal muscle relaxant, in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

An excretion balance and pharmacokinetic study of the novel anticancer agent E7070 in cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The in vivo human metabolism of tibolone

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

High absorption but very low bioavailability of oral resveratrol in humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The metabolism of [14C]N-ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Single-dose accumulation pharmacokinetics of tobramycin and netilmicin in normal volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

14C-isomazole disposition in man after oral administration

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in human

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolic profiles of minimally absorbed orlistat in obese/overweight volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Identifiers

10.1080/03602530600952172

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33278984&oldid=1622139062"